Galderma’s nemolizumab sets new standard in prurigo nodularis treatment with OLYMPIA 1 trial success

Galderma’s latest clinical trial has unveiled a significant breakthrough in treating prurigo nodularis, a chronic neuroimmune skin condition characterized by relentless itching and thickened skin ... Read More